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The dry powder inhaler (DPI) is an increasingly popular delivery device, used 
to deliver a wide variety of drugs to the lung for either local or systemic action. 
With many originator DPI formulations reaching the end of their period of 
patent protection,  the development of DPI products for the generic market is 
an area with much potential. Unlike other pharmaceutical delivery devices, the 
DPI device is as important as the powder blend it contains; it is simply not the 
case that a powder blend can be formulated that matches the originator, 
because its properties must be matched to the device that aerosolizes it (1, 
2). A product will only achieve the desired fine particle fraction (FPF) if the two 
elements are considered together. This fact has particular relevance to the 
generics market in cases where the patent covering the device that generates 
an aerosol expires at a different time to any patents covering the active 
principal or powder blend it contains. 
Particle size reduction 
A critical parameter for successful DPI delivery is particle size; powders need 
to be between 2–4 m in diameter to reach the alveoli and deposit (3). For 
this reason, the active is usually milled (or micronized) prior to formulation 
such that it has the required particle size distribution. Milling, being a high-
energy process, has the potential to fundamentally change the physical form 
of the sample in addition to reducing its particle size. Changing physical form 
(usually an amorphous state is produced) necessarily changes (and usually 
increases) the surface energy of a material and, therefore, impacts its 
cohesiveness and adhesiveness. There has been much research over the 
past 20 years into the nature of the forces that influence how powder blends 
aerosolize, and it is now well established that forces of adhesion and 
cohesion are critical (3). The determination of the amorphous content of milled 
powders is, therefore, crucial; it is usually possible to show that amorphous 
content correlates directly to FPF. For this reason, any submission to the US 
FDA for a DPI product usually requires an analytical method to quantitate 
amorphous content, as well as limits for batches of milled material that may 
be used in commercial batches. 
 
Of the myriad of techniques available to quantitate amorphous content, those 
based on calorimetry are particular useful. The amorphous state is higher in 
energy than any crystalline counterpart and calorimetry measures energy 
directly. The two most popular calorimetric methods are solution (ampoule-
breaking) and gas perfusion (4) (see Sidebar). The former uses heat of 
solution to indicate amorphous content and the latter uses heat of 
crystallization. These methods are excellent and are becoming widely used. 
However, interpretation of calorimetric data is tricky because heat is a 
ubiquitous property and if a calorimetric experiment is not constructed 
properly, the data are easily misinterpreted.  
 
Ten questions to ask 
This article suggests 10 questions that should be asked of any calorimetric 
method, along with the rationales behind them, so that any reader designing, 
undertaking, or reviewing experiments to quantitate amorphous contents by 
calorimetry can do so with critical thought. Before these questions are raised, 
it is worth briefly explaining the principles on which the two methods operate. 
 
Gas perfusion calorimetry: In this method, a plasticizer (usually water or 
ethanol) is perfused over the sample in an inert carrier gas. The sample will 
adsorb and absorb the plasticizer, crystallize, and then expel any absorbed 
solvent. The calorimeter measures these heats as the sample is held at a 
constant temperature (4). Since all of these processes will occur with a 
change in heat, they will all contribute to the final measured heat change. It is 
essential that the method corrects for these values if the heat of crystallization 
is needed. Typical power-time data for a partially amorphous material are 
shown in Figure 1. 
 
Solution (ampoule-breaking) calorimetry: In this method, the sample is 
contained within a sealed ampoule and a reservoir of solvent (up to 100 mL) 
is allowed to reach thermal equilibrium. The ampoule is then broken and the 
powdered sample is exposed to the solvent. Rapid dissolution should ensue, 
and the heat of solution is measured (5). The technique is particularly suited 
to amorphous content quantification because crystalline materials typically 
have an endothermic heat of solution while amorphous materials have an 
exothermic heat of solution. Typical power-time data for a partially amorphous 
material are shown in Figure 1. 
 
1) Is the particle size of the sample the same each time and/or the same as 
the material used for the calibration curve? 
 
Particle size is most important where gas perfusion calorimetry is used. If the 
particle size of the sample is different from that of the material used to 
generate the calibration curve, or varies from batch to batch, then the 
proportion of the total heat change arising from adsorption will vary. This heat 
change? must be corrected for, or an incorrect heat of crystallization will be 
measured (see question 5). If solution calorimetry is used, changing particle 
size will change the rate of dissolution of the material, which will alter the 
shape of the power-time data but will not affect the total heat. 
 
2) Does the sample exhibit polymorphism? 
 
Different polymorphs will have different heats of solution or crystallization. 
Therefore, it does not matter which calorimetric method is used, the 
calibration curve must be generated with material of the same polymorphic 
form as that being tested. A good check, in the case of gas perfusion 
experiments, is to remove the sample after the experiment and to check the 
polymorphic form of the sample with X-ray diffraction, differential scanning 
calorimetry (DSC), or any other suitable method. Obviously, if a material is 
amorphous, it has no crystal structure, but most milled powders have only a 
small (<5% w/w) amorphous fraction, with the remainder being crystalline. 
The form to which it crystallises, or the form that dissolves, is therefore critical. 
 
3) Is the material anomeric? 
 
Sugars are anomeric (i.e., they differ in conformation in their cyclic ring 
structure at either the C1, C2, or C5 carbon atoms). For instance,  lactose 
and  lactose are anomers of each other. The heat of crystallization or 
solution of each anomer is different, so as in the case of polymorphic 
materials, the calibration curve must be generated with material of the same 
anomeric form (or ratio) as that being tested. Ramos et al. (6) demonstrated 
the effect of the anomeric composition of lactose on amorphous calibration 
curves prepared by solution and gas perfusion calorimetry (shown in Figure 
2). Importantly, unlike polymorphism, the anomeric structure is retained in the 
amorphous form because it is an intra-molecular property, not an inter-
molecular property. A further complication is that anomeric sugars will 
frequently mutarotate under conditions of high humidity, meaning they change 
anomeric ratio. Finally,  lactose forms a monohydrate while  lactose is 
anhydrous. All of these processes will occur with a change in heat, or will 
cause a change in heat of solution. 
 
4) What plasticizer or solvent is being used? 
 
The use of a plasticizer applies only to gas perfusion experiments. Many small 
organic molecules will plasticize pharmaceuticals. Water might even plasticize 
a poorly water-soluble active sufficiently to cause recrystallization. However, 
the rate at which crystallization occurs, as well as the heats of adsorption and 
absorption, will vary with the plasticizer. Therefore, the plasticizer should (a) 
be optimized for the sample being studied and (b) be the sample for 
processed samples and those used to generate the calibration curve.  
 
The use of solvents applies only to solution calorimetry experiments. The heat 
of solution of a compound will vary depending on the solvent into which it is 
dissolving. One of the benefits of solution calorimetry is that if the compound 
being studied is poorly water-soluble, an organic solvent can be used instead. 
It is crucial, however, that the same solvent is used for processed samples as 
well as those used to generate the calibration curve. It must also be 
remembered that many organic solvents are volatile, and may well evaporate 
from the calorimeter during the measurement. This process is endothermic 
and  will, therefore, contribute to the measured heat signal. 
 
5) Is the method a comparison of wetting responses? 
 
This question applies only to gas perfusion experiments. The quickest way to 
assess a milled sample is to expose it to a plasticizer and measure the heat. 
However, as noted above, the heat measured this way includes contributions 
from adsorption, absorption, and expulsion of the plasticizer. It has been 
argued that the heats of absorption and expulsion should be equal and 
opposite, and so cancel each other out. However, the heat of adsorption 
remains and the only way to correct for it is to dry the sample and then re-
expose it to plasticizer. This approach not only provides the heat of 
adsorption, it also unequivocally demonstrates that the sample underwent an 
irreversible phase transition during the initial exposure to plasticizer 
(reaffirming the material was partially amorphous). Figure 3 shows the power-
time data for amorphous and crystalline samples of salbutamol sulphate when 
exposed to two phases of elevated humidity (90%). There are several 
important points to note:  
 the response of the amorphous material to humidity is initially much 
larger than that of the crystalline material (which is why gas perfusion is 
so sensitive to small amorphous contents), but the data are complex 
and contain many phases—it is not easy in this case to determine 
which area to measure  
 upon exposure to humidity for a second time, the response of the 
amorphous material has reduced significantly—this observation 
indicates that an irreversible event occurred during the initial exposure 
to humidity, and it also suggests that the powder mass has fused 
during crystallization, reducing its surface area to less than that of the 
crystalline reference sample. 
 
6) Can the sample form a hydrate or solvate? 
 
If the sample can form a hydrate or solvate with the plasticizer, then the power 
signal may become complex in shape, especially where formation occurs over 
an extended time period. This makes determination of the heat of 
crystallization either difficult (because it is not easy to determine which section 
of data to integrate) or time-consuming (because conversion must progress to 
completion).  
Further complicating factors to consider in these cases include:  
 whether the sample could have formed a hydrate or solvate prior to or 
after milling  
 whether the samples used to make the calibration curve were hydrates 
or solvates  
 if a hydrate or solvate is formed directly on crystallization of the 
amorphous fraction, the heats of absorption and expulsion of the 
plasticizer will not cancel out (less plasticizer is expelled).  
Ideally, a plasticizer would be selected with which the sample cannot form 
a hydrate or solvate. Returning to the example of salbutamol sulphate 
shown in Figure 3, the data are complex because the drug absorbs water 
and crystallizes to a mono-hydrate (7). The situation for salbutamol 
sulphate becomes more complicated if some crystalline drug is also 
present, because the anhydrate form is most stable. In this case, the 
amorphous fraction crystallizes to a monohydrate, but then slowly 
dehydrates to form the anhydrate with time (see Figure 4). Again, care 
must be taken when devising the experimental methodology for samples 
such as this, to ensure the heat measured is actually proportional to the 
amorphous fraction and does not result from some additional process. 
 
7) Is the milled material sourced from different suppliers? 
 
Milling is a high-energy process, and the way the energy is imparted to the 
sample can do more than simply reduce particle size. In principle, large 
particles will initially fracture when the mill imparts energy, but once their size 
has reduced sufficiently, they will reach their brittle-ductile point, at which 
further size reduction is unlikely. Any energy provided after this point will not 
cause size reduction, but must still be dissipated by the sample—most likely 
by disrupting crystal structure, which is why milled materials are usually 
partially amorphous. The data in Figure 5 illustrate this point for salbutamol 
sulphate. The parameters for milling are usually adjusted to optimize particle 
size distribution of the milled powder only; no consideration is given to the 
physical form of the material. Hence, powders with similar particle size 
distributions produced from different mills may well have appreciably different 
amorphous contents. Consequently, they will not process or blend in the 
same way, and DPI performance will be affected. 
 
8) Are samples analyzed at the same time after milling? 
 
The amorphous state is simple to define (lack of long-range crystal structure) 
but poorly understood. This complexity? is because it is a high-energy state 
and, unlike crystal lattices, an infinite number of arrangements of molecules is 
possible. Hence, the energy of an amorphous material will lie in a range of 
values above any crystalline forms. With time, the molecules in an amorphous 
matrix will move and reorient (i.e., the process of relaxation). Because 
spontaneous molecular rearrangement can only progress in the direction of 
increasing order, as an amorphous material relaxes, it will lose energy as its 
molecular structure  changes to that of the nearest crystalline form (and, 
indeed, many amorphous materials will eventually crystallize). As  the 
performance of a DPI formulation is critically dependent on the forces of 
adhesion and cohesion, relaxation of a milled powder prior to blending can 
significantly affect the FPF achieved. This is, in fact, the reason many milled 
powders are conditioned prior to blending, either under humidity or left for a 
period of time. It follows that the time period between milling and 
measurement of amorphous content is critical—with longer time, more 
relaxation will have occurred and a lower amorphous content will be 
measured. A good protocol is to define a maximum time period permissible 
between milling and amorphous content quantification (three days, for 
example) and ensure all milled samples are stored in sealed, desiccated 
containers. 
 
9) How was the amorphous reference material prepared? 
 
The definition of an amorphous material as lacking long-range molecular 
order does not preclude the possibility that there is appreciable short-range 
structuring. The degree of short-range order in an amorphous material is 
affected by the method of production. Consequently, amorphous materials of 
the sample compound prepared by, for example, spray-drying, lyophilization 
(freeze-drying), and quench-cooling will often behave very differently. In 
simplistic terms, the faster the method of production, the less time the 
molecules in a sample have to orient. Hence, a calibration curve prepared 
with amorphous material will often be different from a calibration curve 
prepared with freeze-dried material, because the energy contents of the two 
amorphous materials will be different. A further consideration is that 
irrespective of the method used to make the amorphous standards, it is likely 
that the short-range order imparted by milling will be different and so, in the 
opinion of the author, no calibration curve is representative of the sample 
being tested. 
 
10) Is percent amorphous content actually needed? 
 
Determining the percent of amorphous content needed is a complicated 
concept, related to the concepts of relaxation and the problem of amorphous 
reference standards as discussedpreviously. The actual value determined by 
either solution or gas perfusion calorimetry is a heat, which can be considered 
as the excess energy of any amorphous fraction of a milled sample. While it is 
clearly possible to define some fraction of a sample as crystalline and the rest 
amorphous (and so also to use percentages), hopefully, it is apparent that as 
any amorphous fraction of a milled material relaxes, its excess energy will 
reduce. If the value of the excess energy is then converted to a percent 
amorphous content, by reference to a calibration curve, it will appear to 
reduce with time. However, the actual proportion of the material that is 
crystalline has not changed. It is simply the case that the energy of the 
amorphous fraction is reducing. The situation is further complicated when one 
remembers the problems in choosing appropriate amorphous reference 
standards for the calibration curve. In the opinion of the author, it is a better 
concept to correlate excess energy with FPF than percent amorphous 
content, because ultimately, it is the energy of the material that influences 
forces of adhesion and cohesion. An additional benefit of this approach is that 
a calibration curve for percent amorphous content is not needed.  
Conclusion 
In summary, calorimetric techniques are excellent choices for identifying, 
characterizing, and quantifying partially amorphous materials. There is little 
doubt that if the physical properties of a material have changed during 
processing, calorimetric analysis will show a difference. The issue relates to 
interpretation of the data, because heat is a universal indicator of physical 
change. If the experimental design is not well constructed or the nature of the 
material being investigated is not thoroughly understood, it is very easy to 
misinterpret the data. Hopefully, by asking some or all of the questions raised 
in this article, readers will be better informed when quantifying small 
amorphous contents with calorimetric methods. 
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Figure 1. Schematic representations of typical power-time data for responses 
of a partially amorphous sample to increased humidity (top) and to dissolution 
(bottom). In both cases, integration of the area under curve (AUC) gives the 
heat of the process.  
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Figure 2. Calibration curves of amorphous content versus heat of 
crystallization (top) and heat of solution (bottom), showing the effect of the 
anomeric form of the sample. 
 
  
 
 
Figure 3. Power–time data for salbutamol sulphate (both amorphous and 
crystalline materials are shown) when exposed to successive environments of 
elevated relative humidity. The response of the amorphous material is initially 
much greater, as it crystallizes to a monohydrate, but is actually smaller than 
the crystalline material in the second phase, because particle fusion has 
reduced its surface area. 
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 Figure 4. When amorphous salbutamol sulphate is exposed to elevated (90%) 
humidity it crystallizes to form a monohydrate (grey line) but if some 
crystalline salbutamol sulphate is present, the monohydrate slowly converts to 
the anhydrate form with time (endothermic, black line?). 
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 Figure 5. A plot showing the reduction in particle size (squares) when 
salbutamol sulphate is milled in a ball mill and the corresponding amorphous 
content measured by gas perfusion calorimetry (circles). It is apparent that 
initially particle size reduction occurs rapidly and without generation of 
amorphous material, but with time no further reduction in particle size is seen 
and the energy imparted by the mill causes disruption of crystal structure. 
